Biotech companies use recombinant DNA to insert genes coding for useful products into bacteria and other organisms, turning them into tiny factories for making things from medicine to industrial ...

The global Recombinant DNA Technology Market was valued USD 142.9 Billion in 2021 and is all set to surpass USD 223.0 Billion by 2028, exhibiting a CAGR of 7.7% during the forecast period 2022-2028.

Therefore, the use of recombinant DNA technology was an attractive option for development of a vaccine that solved both of these problems.